Takeda Pharmaceutical revenue and financials
¥5,766.00Change from previous close: +0.82%Absolute change: +¥47.00
In the fiscal year ended March 2026, Takeda Pharmaceutical reported revenue of ¥4.51T (−1.66% year over year). The net loss was ¥152.39B.
Fiscal year ending in March. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- −1.66%
- FY to Mar 2026 vs FY to Mar 2025
- Net margin
- -3.4%
- FY to Mar 2025: 2.4%
Financial data
Amounts in millions of JPY; per-share values in JPY; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Total assets | 15,663,271 | 15,511,506 | 15,408,774 | 14,470,300 | 14,004,537 | — |
| Current assets | 3,150,269 | 3,090,503 | 3,116,439 | 2,920,620 | 2,513,122 | — |
| Cash and equivalents | 460,982 | 595,054 | 654,937 | 681,486 | 350,008 | — |
| Short-term investments | 66,600 | 41,888 | 107,004 | 58,192 | 69,167 | — |
| Receivables | 956,140 | 876,348 | 757,921 | 702,238 | 679,531 | — |
| Inventory | 1,447,259 | 1,396,620 | 1,407,192 | 1,299,486 | 1,240,676 | — |
| Net property, plant and equipment | 2,142,280 | 2,120,639 | 2,083,981 | 1,984,126 | 1,956,269 | — |
| Goodwill | 5,886,905 | 5,809,010 | 5,753,268 | 5,431,698 | 5,295,871 | — |
| Other intangible assets | 3,391,152 | 3,419,348 | 3,515,628 | 3,299,225 | 3,422,542 | — |
| Long-term investments | 473,218 | 448,737 | 434,168 | 374,332 | 347,120 | — |
| Current liabilities | 2,764,547 | 2,832,074 | 2,610,183 | 2,139,655 | 2,169,586 | — |
| Accounts payable | 446,784 | 324,368 | 467,594 | 438,985 | 421,308 | — |
| Long-term debt | 4,419,998 | 4,369,681 | 4,270,174 | 4,351,462 | 4,134,799 | — |
| Total debt | 4,939,968 | 4,881,838 | 4,853,321 | 4,645,320 | 4,505,942 | — |
| Total liabilities | 8,104,395 | 8,080,857 | 7,764,684 | 7,338,611 | 7,138,357 | — |
| Total equity (incl. minority) | 7,558,876 | 7,430,649 | 7,644,090 | 7,131,689 | 6,866,180 | — |
| Retained earnings | 667,007 | 712,381 | 1,095,662 | 1,148,658 | 1,156,692 | — |
| Minority interest | 989 | 1,208 | 1,147 | 992 | 921 | — |